Stryker Corporation SYK
272.36
2.61
0.97%
as of 25 Sep
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Stryker Corporation (SYK) P/E ratio
As of 25 September 2026, Stryker Corporation (SYK) trades at a P/E ratio of 28.0×. Over the past ten years it has ranged from 16.1× (January 2019) to 71.2× (April 2021); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 41.4× | (9.74%) |
| FY2024 | 45.9× | 29.13% |
| FY2023 | 35.5× | (10.06%) |
| FY2022 | 39.5× | (21.88%) |
| FY2021 | 50.6× | (11.91%) |
| FY2020 | 57.4× | 52.25% |
| FY2019 | 37.7× | 128.19% |
| FY2018 | 16.5× | (71.44%) |
| FY2017 | 57.8× | 113.57% |
| FY2016 | 27.1× | 11.31% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 32.4× | (14.03%) |
| Mar 2026 | 37.6× | (9.08%) |
| Dec 2025 | 41.4× | (13.66%) |
| Sep 2025 | 47.9× | (7.41%) |
| 42 more quarters | Free account |
Against its own ten years
Low 16.1×
High 71.2×
Ten-year median
40.0×
Current reading's percentile
18
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| BSX Boston Scientific Corporation compare | 17.7× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| MDT Medtronic PLC compare | 21.7× |
| STE STERIS plc compare | 25.4× |
| SYK Stryker Corporation | 28.0× |
| ABT Abbott Laboratories compare | 32.8× |
| DXCM DexCom, Inc. compare | 33.4× |
| EW Edwards Lifesciences Corporation compare | 49.6× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement